Loading clinical trials...
Loading clinical trials...
A Phase 2b Double-blind, Randomized, Placebo-controlled, Parallel-group Study of the Efficacy and Safety of Norketotifen (NKT) in the Treatment of Acute Uncomplicated Influenza-like Illness (ILI)
Conditions
Interventions
Norketotifen
Placebo
Locations
18
United States
Cahaba Research
Birmingham, Alabama, United States
Precision Trials AZ
Phoenix, Arizona, United States
Long Beach Clinical Trial Services
Long Beach, California, United States
Empire Clinical Research
Pomona, California, United States
Northern California Research
Sacramento, California, United States
AFC Urgent Care
Denver, Colorado, United States
Start Date
October 21, 2019
Primary Completion Date
April 5, 2020
Completion Date
April 20, 2020
Last Updated
March 24, 2021
Lead Sponsor
Emergo Therapeutics, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions